Outcome of Board Meeting_01.11.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025. Standalone revenue for Q2 FY26 stood at ₹4,737 lakh, while H1 FY26 revenue fell sharply to ₹8,697 lakh from ₹11,097 lakh in H1 FY25, a decline of about 22%. Standalone profit after tax for H1 FY26 dropped to ₹183 lakh from ₹769 lakh a year earlier, reflecting significant margin compression. The consolidated picture showed similar weakness with H1 revenue at ₹10,936 lakh (vs ₹11,902 lakh) and PAT at ₹139 lakh (vs ₹879 lakh). The Board also noted the transfer of shares of Josts Foundation on October 8, 2025, resulting in it ceasing to be a wholly owned subsidiary. Additionally, the Board took note of a Rights Issue completed on September 16, 2025, where ₹4,989.37 lakh was raised through allotment of 18.48 lakh shares at ₹270 per share, of which ₹1,830.22 lakh was utilised in Q2 for working capital and issue expenses.
Weak top-line and sharply lower profits signal business headwinds that could weigh on the stock. The rights issue proceeds are being deployed as planned with no deviation reported, providing some comfort on capital management.